Industry Experts

Alexander oversees commercial strategy for Immuto’s high-throughput protein-characterization platform. Trained in biochemistry, mathematics, and computer science at Northeastern University, he applied his interdisciplinary background across roles at Harvard School of Public Health, Moderna, and Massachusetts General Hospital. In these settings, he supported research initiatives through data-driven approaches and cross-functional collaboration. At PGDx, he integrated next-generation sequencing into CAP/CLIA workflows. His focus today is turning residue-level structural data into practical tools for antibody discovery and rational therapeutic design.